1. Park E, Pan Z, Zhang Z, Lin L, and Xing Y. The Expanding Landscape of Alternative Splicing Variation in Human Populations. Am J Hum Genet. 2018;102:11-26. https://doi.org/10.1016/j.ajhg.2017.11.002.
2. Weirather JL, de Cesare M, Wang Y, Piazza P, Sebastiano V, Wang XJ, et al. Comprehensive comparison of Pacific Biosciences and Oxford Nanopore Technologies and their applications to transcriptome analysis. F1000Res. 2017;6:100. https://doi.org/10.12688/f1000research.10571.2.
3. Piovesan A, Antonaros F, Vitale L, Strippoli P, Pelleri MC, and Caracausi M. Human protein-coding genes and gene feature statistics in 2019. BMC Res Notes. 2019;12:315. https://doi.org/10.1186/s13104-019-4343-8.
4. Nilsen TW and Graveley BR. Expansion of the eukaryotic proteome by alternative splicing. Nature. 2010;463:457-63. https://doi.org/10.1038/nature08909.
5. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, et al. Alternative isoform regulation in human tissue transcriptomes. Nature. 2008;456:470-6. https://doi.org/10.1038/nature07509.
6. Pan Q, Shai O, Lee LJ, Frey BJ, and Blencowe BJ. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet. 2008;40:1413-5. https://doi.org/10.1038/ng.259.
7. Yeo G, Hoon S, Venkatesh B, and Burge CB. Variation in sequence and organization of splicing regulatory elements in vertebrate genes. Proc Natl Acad Sci U S A. 2004;101:15700-5. https://doi.org/10.1073/pnas.0404901101.
8. Yang YY, Yin GL, and Darnell RB. The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia. Proc Natl Acad Sci U S A. 1998;95:13254-9. https://doi.org/10.1073/pnas.95.22.13254.
9. McKee AE, Minet E, Stern C, Riahi S, Stiles CD, and Silver PA. A genome-wide in situ hybridization map of RNA-binding proteins reveals anatomically restricted expression in the developing mouse brain. BMC Dev Biol. 2005;5:14. https://doi.org/10.1186/1471-213X-5-14.
10. Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, et al. Landscape of transcription in human cells. Nature. 2012;489:101-8. https://doi.org/10.1038/nature11233.
11. Gonzalez-Porta M, Frankish A, Rung J, Harrow J, and Brazma A. Transcriptome analysis of human tissues and cell lines reveals one dominant transcript per gene. Genome Biol. 2013;14:R70. https://doi.org/10.1186/gb-2013-14-7-r70.
12. Tress ML, Abascal F, and Valencia A. Most Alternative Isoforms Are Not Functionally Important. Trends Biochem Sci. 2017;42:408-10. https://doi.org/10.1016/j.tibs.2017.04.002.
13. Kim N, Jeong E, Wang X, and Yoon S. Dissecting the global variation of gene expression for the functional interpretation of transcriptome data. Genomics. 2014;104:279-86. https://doi.org/10.1016/j.ygeno.2014.08.001.
14. Schreiner D, Simicevic J, Ahrne E, Schmidt A, and Scheiffele P. Quantitative isoform-profiling of highly diversified recognition molecules. Elife. 2015;4:e07794. https://doi.org/10.7554/eLife.07794.
15. Weatheritt RJ, Sterne-Weiler T, and Blencowe BJ. The ribosome-engaged landscape of alternative splicing. Nat Struct Mol Biol. 2016;23:1117-23. https://doi.org/10.1038/nsmb.3317.
16. Pantazatos SP, Andrews SJ, Dunning-Broadbent J, Pang J, Huang YY, Arango V, et al. Isoform-level brain expression profiling of the spermidine/spermine N1-Acetyltransferase1 (SAT1) gene in major depression and suicide. Neurobiol Dis. 2015;79:123-34. https://doi.org/10.1016/j.nbd.2015.04.014.
17. Ma L, Shcherbina A, and Chetty S. Variations and expression features of CYP2D6 contribute to schizophrenia risk. Mol Psychiatry. 2021;26:2605-15. https://doi.org/10.1038/s41380-020-0675-y.
18. Gandal MJ, Zhang P, Hadjimichael E, Walker RL, Chen C, Liu S, et al. Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder. Science. 2018;362. https://doi.org/10.1126/science.aat8127.
19. Akula N, Barb J, Jiang X, Wendland JR, Choi KH, Sen SK, et al. RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms and GTPase binding in bipolar disorder. Mol Psychiatry. 2014;19:1179-85. https://doi.org/10.1038/mp.2013.170.
20. Marques-Coelho D, Iohan L, Melo de Farias AR, Flaig A, Lambert JC, and Costa MR. Differential transcript usage unravels gene expression alterations in Alzheimer's disease human brains. NPJ Aging Mech Dis. 2021;7:2. https://doi.org/10.1038/s41514-020-00052-5.
21. Raj T, Li YI, Wong G, Humphrey J, Wang M, Ramdhani S, et al. Integrative transcriptome analyses of the aging brain implicate altered splicing in Alzheimer's disease susceptibility. Nat Genet. 2018;50:1584-92. https://doi.org/10.1038/s41588-018-0238-1.
22. Del-Aguila JL, Benitez BA, Li Z, Dube U, Mihindukulasuriya KA, Budde JP, et al. TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers. Mol Neurodegener. 2019;14:18. https://doi.org/10.1186/s13024-019-0319-3.
23. Chen W and Moore MJ. Spliceosomes. Curr Biol. 2015;25:R181-3. https://doi.org/10.1016/j.cub.2014.11.059.
24. Kwon SM, Min S, Jeoun UW, Sim MS, Jung GH, Hong SM, et al. Global spliceosome activity regulates entry into cellular senescence. FASEB J. 2021;35:e21204. https://doi.org/10.1096/fj.202000395RR.
25. Emilsson V, Thorleifsson G, Zhang B, Leonardson AS, Zink F, Zhu J, et al. Genetics of gene expression and its effect on disease. Nature. 2008;452:423-8. https://doi.org/10.1038/nature06758.
26. De Paoli-Iseppi R, Gleeson J, and Clark MB. Isoform Age - Splice Isoform Profiling Using Long-Read Technologies. Front Mol Biosci. 2021;8:711733. https://doi.org/10.3389/fmolb.2021.711733.
27. Lim KH, Ferraris L, Filloux ME, Raphael BJ, and Fairbrother WG. Using positional distribution to identify splicing elements and predict pre-mRNA processing defects in human genes. Proc Natl Acad Sci U S A. 2011;108:11093-8. https://doi.org/10.1073/pnas.1101135108.
28. Irimia M, Weatheritt RJ, Ellis JD, Parikshak NN, Gonatopoulos-Pournatzis T, Babor M, et al. A highly conserved program of neuronal microexons is misregulated in autistic brains. Cell. 2014;159:1511-23. https://doi.org/10.1016/j.cell.2014.11.035.
29. Parikshak NN, Swarup V, Belgard TG, Irimia M, Ramaswami G, Gandal MJ, et al. Genome-wide changes in lncRNA, splicing, and regional gene expression patterns in autism. Nature. 2016;540:423-7. https://doi.org/10.1038/nature20612.
30. Quesnel-Vallieres M, Dargaei Z, Irimia M, Gonatopoulos-Pournatzis T, Ip JY, Wu M, et al. Misregulation of an Activity-Dependent Splicing Network as a Common Mechanism Underlying Autism Spectrum Disorders. Mol Cell. 2016;64:1023-34. https://doi.org/10.1016/j.molcel.2016.11.033.
31. Xiong HY, Alipanahi B, Lee LJ, Bretschneider H, Merico D, Yuen RK, et al. RNA splicing. The human splicing code reveals new insights into the genetic determinants of disease. Science. 2015;347:1254806. https://doi.org/10.1126/science.1254806.
32. Lin L, Park JW, Ramachandran S, Zhang Y, Tseng YT, Shen S, et al. Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease. Hum Mol Genet. 2016;25:3454-66. https://doi.org/10.1093/hmg/ddw187.
33. Elorza A, Marquez Y, Cabrera JR, Sanchez-Trincado JL, Santos-Galindo M, Hernandez IH, et al. Huntington's disease-specific mis-splicing unveils key effector genes and altered splicing factors. Brain. 2021;144:2009-23. https://doi.org/10.1093/brain/awab087.
34. Naryshkin NA, Weetall M, Dakka A, Narasimhan J, Zhao X, Feng Z, et al. Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy. Science. 2014;345:688-93. https://doi.org/10.1126/science.1250127.
35. Gao D, Morini E, Salani M, Krauson AJ, Chekuri A, Sharma N, et al. A deep learning approach to identify gene targets of a therapeutic for human splicing disorders. Nat Commun. 2021;12:3332. https://doi.org/10.1038/s41467-021-23663-2.
36. Finkel RS, Chiriboga CA, Vajsar J, Day JW, Montes J, De Vivo DC, et al. Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study. Lancet. 2016;388:3017-26. https://doi.org/10.1016/S0140-6736(16)31408-8.
37. Montes M, Sanford BL, Comiskey DF, and Chandler DS. RNA Splicing and Disease: Animal Models to Therapies. Trends Genet. 2019;35:68-87. https://doi.org/10.1016/j.tig.2018.10.002.
38. Lejman J, Zielinski G, Gawda P, and Lejman M. Alternative Splicing Role in New Therapies of Spinal Muscular Atrophy. Genes (Basel). 2021;12. https://doi.org/10.3390/genes12091346.
39. Xia C, Ma T, Jiao C, Chen C, and Liu C. BrainEXP-NPD: a database of transcriptomic profiles of human brains of six neuropsychiatric disorders. bioRxiv. 2021:2021.05.30.446363. https://doi.org/10.1101/2021.05.30.446363.
40. Johnson WE, Li C, and Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8:118-27. https://doi.org/10.1093/biostatistics/kxj037.
41. Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47. https://doi.org/10.1093/nar/gkv007.
42. Benjamini Y and Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B. 1995:289-300. https://doi.org/http://www.jstor.org/stable/2346101.
43. !!! INVALID CITATION !!! (16).
44. Papasaikas P, Tejedor JR, Vigevani L, and Valcarcel J. Functional splicing network reveals extensive regulatory potential of the core spliceosomal machinery. Mol Cell. 2015;57:7-22. https://doi.org/10.1016/j.molcel.2014.10.030.
45. Verduci L, Simili M, Rizzo M, Mercatanti A, Evangelista M, Mariani L, et al. MicroRNA (miRNA)-mediated interaction between leukemia/lymphoma-related factor (LRF) and alternative splicing factor/splicing factor 2 (ASF/SF2) affects mouse embryonic fibroblast senescence and apoptosis. J Biol Chem. 2010;285:39551-63. https://doi.org/10.1074/jbc.M110.114736.
46. Tang Y, Horikawa I, Ajiro M, Robles AI, Fujita K, Mondal AM, et al. Downregulation of splicing factor SRSF3 induces p53beta, an alternatively spliced isoform of p53 that promotes cellular senescence. Oncogene. 2013;32:2792-8. https://doi.org/10.1038/onc.2012.288.
47. Blanco FJ and Bernabeu C. The Splicing Factor SRSF1 as a Marker for Endothelial Senescence. Front Physiol. 2012;3:54. https://doi.org/10.3389/fphys.2012.00054.
48. Rodriguez SA, Grochova D, McKenna T, Borate B, Trivedi NS, Erdos MR, et al. Global genome splicing analysis reveals an increased number of alternatively spliced genes with aging. Aging Cell. 2016;15:267-78. https://doi.org/10.1111/acel.12433.
49. Shimada N, Rios I, Moran H, Sayers B, and Hubbard K. p38 MAP kinase-dependent regulation of the expression level and subcellular distribution of heterogeneous nuclear ribonucleoprotein A1 and its involvement in cellular senescence in normal human fibroblasts. RNA Biol. 2009;6:293-304. https://doi.org/10.4161/rna.6.3.8497.
50. Jassal B, Matthews L, Viteri G, Gong C, Lorente P, Fabregat A, et al. The reactome pathway knowledgebase. Nucleic Acids Res. 2020;48:D498-D503. https://doi.org/10.1093/nar/gkz1031.
51. Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021;49:D605-D12. https://doi.org/10.1093/nar/gkaa1074.
52. Mullins N, Forstner AJ, O'Connell KS, Coombes B, Coleman JRI, Qiao Z, et al. Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. Nat Genet. 2021;53:817-29. https://doi.org/10.1038/s41588-021-00857-4.
53. Grove J, Ripke S, Als TD, Mattheisen M, Walters RK, Won H, et al. Identification of common genetic risk variants for autism spectrum disorder. Nat Genet. 2019;51:431-44. https://doi.org/10.1038/s41588-019-0344-8.
54. Howard DM, Adams MJ, Clarke TK, Hafferty JD, Gibson J, Shirali M, et al. Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat Neurosci. 2019;22:343-52. https://doi.org/10.1038/s41593-018-0326-7.
55. Jansen IE, Savage JE, Watanabe K, Bryois J, Williams DM, Steinberg S, et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk. Nat Genet. 2019;51:404-13. https://doi.org/10.1038/s41588-018-0311-9.
56. Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres-Ciga S, Chang D, et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 2019;18:1091-102. https://doi.org/10.1016/S1474-4422(19)30320-5.
57. Sullivan P. scz2021. 2021. https://doi.org/https://doi.org/10.6084/m9.figshare.14672178.v1.
58. Gandal MJ, Zhang P, Hadjimichael E, Walker RL, Chen C, Liu S, et al. Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder. Science. 2018;362. https://doi.org/10.1126/science.aat8127.
59. Wang D, Liu S, Warrell J, Won H, Shi X, Navarro FCP, et al. Comprehensive functional genomic resource and integrative model for the human brain. Science. 2018;362. https://doi.org/10.1126/science.aat8464.
60. !!! INVALID CITATION !!! [49, 50].
61. Barbeira AN, Dickinson SP, Bonazzola R, Zheng J, Wheeler HE, Torres JM, et al. Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics. Nat Commun. 2018;9:1825. https://doi.org/10.1038/s41467-018-03621-1.
62. Goren A, Ram O, Amit M, Keren H, Lev-Maor G, Vig I, et al. Comparative analysis identifies exonic splicing regulatory sequences--The complex definition of enhancers and silencers. Mol Cell. 2006;22:769-81. https://doi.org/10.1016/j.molcel.2006.05.008.
63. Ule J and Darnell RB. RNA binding proteins and the regulation of neuronal synaptic plasticity. Curr Opin Neurobiol. 2006;16:102-10. https://doi.org/10.1016/j.conb.2006.01.003.
64. Wang Z, Rolish ME, Yeo G, Tung V, Mawson M, and Burge CB. Systematic identification and analysis of exonic splicing silencers. Cell. 2004;119:831-45. https://doi.org/10.1016/j.cell.2004.11.010.
65. Verma B, Akinyi MV, Norppa AJ, and Frilander MJ. Minor spliceosome and disease. Semin Cell Dev Biol. 2018;79:103-12. https://doi.org/10.1016/j.semcdb.2017.09.036.
66. Lee YR, Khan K, Armfield-Uhas K, Srikanth S, Thompson NA, Pardo M, et al. Mutations in FAM50A suggest that Armfield XLID syndrome is a spliceosomopathy. Nat Commun. 2020;11:3698. https://doi.org/10.1038/s41467-020-17452-6.
67. Armfield K, Nelson R, Lubs HA, Hane B, Schroer RJ, Arena F, et al. X-linked mental retardation syndrome with short stature, small hands and feet, seizures, cleft palate, and glaucoma is linked to Xq28. Am J Med Genet. 1999;85:236-42. https://doi.org/10.1002/(sici)1096-8628(19990730)85:3<236::aid-ajmg10>3.0.co;2-9.
68. Lau PP, Zhu HJ, Nakamuta M, and Chan L. Cloning of an Apobec-1-binding protein that also interacts with apolipoprotein B mRNA and evidence for its involvement in RNA editing. J Biol Chem. 1997;272:1452-5. https://doi.org/10.1074/jbc.272.3.1452.
69. Bertram K, Agafonov DE, Dybkov O, Haselbach D, Leelaram MN, Will CL, et al. Cryo-EM Structure of a Pre-catalytic Human Spliceosome Primed for Activation. Cell. 2017;170:701-13 e11. https://doi.org/10.1016/j.cell.2017.07.011.
70. Davis TL, Walker JR, Campagna-Slater V, Finerty PJ, Paramanathan R, Bernstein G, et al. Structural and biochemical characterization of the human cyclophilin family of peptidyl-prolyl isomerases. PLoS Biol. 2010;8:e1000439. https://doi.org/10.1371/journal.pbio.1000439.
71. Jurica MS, Licklider LJ, Gygi SR, Grigorieff N, and Moore MJ. Purification and characterization of native spliceosomes suitable for three-dimensional structural analysis. RNA. 2002;8:426-39. https://doi.org/10.1017/s1355838202021088.
72. Zhang X, Yan C, Zhan X, Li L, Lei J, and Shi Y. Structure of the human activated spliceosome in three conformational states. Cell Res. 2018;28:307-22. https://doi.org/10.1038/cr.2018.14.
73. Zhan X, Yan C, Zhang X, Lei J, and Shi Y. Structures of the human pre-catalytic spliceosome and its precursor spliceosome. Cell Res. 2018;28:1129-40. https://doi.org/10.1038/s41422-018-0094-7.
74. Martelly W, Fellows B, Senior K, Marlowe T, and Sharma S. Identification of a noncanonical RNA binding domain in the U2 snRNP protein SF3A1. RNA. 2019;25:1509-21. https://doi.org/10.1261/rna.072256.119.
75. Stegeman R, Spreacker PJ, Swanson SK, Stephenson R, Florens L, Washburn MP, et al. The Spliceosomal Protein SF3B5 is a Novel Component of Drosophila SAGA that Functions in Gene Expression Independent of Splicing. J Mol Biol. 2016;428:3632-49. https://doi.org/10.1016/j.jmb.2016.05.009.
76. Lynch DC, Revil T, Schwartzentruber J, Bhoj EJ, Innes AM, Lamont RE, et al. Disrupted auto-regulation of the spliceosomal gene SNRPB causes cerebro-costo-mandibular syndrome. Nat Commun. 2014;5:4483. https://doi.org/10.1038/ncomms5483.
77. Bacrot S, Doyard M, Huber C, Alibeu O, Feldhahn N, Lehalle D, et al. Mutations in SNRPB, encoding components of the core splicing machinery, cause cerebro-costo-mandibular syndrome. Hum Mutat. 2015;36:187-90. https://doi.org/10.1002/humu.22729.
78. Tooley M, Lynch D, Bernier F, Parboosingh J, Bhoj E, Zackai E, et al. Cerebro-costo-mandibular syndrome: Clinical, radiological, and genetic findings. Am J Med Genet A. 2016;170A:1115-26. https://doi.org/10.1002/ajmg.a.37587.
79. Mordovkina D, Lyabin DN, Smolin EA, Sogorina EM, Ovchinnikov LP, and Eliseeva I. Y-Box Binding Proteins in mRNP Assembly, Translation, and Stability Control. Biomolecules. 2020;10. https://doi.org/10.3390/biom10040591.
80. Wang GS and Cooper TA. Splicing in disease: disruption of the splicing code and the decoding machinery. Nat Rev Genet. 2007;8:749-61. https://doi.org/10.1038/nrg2164.
81. Rubio CA and Riddell RH. Atypical mitoses in dysplasias of the Barrett's mucosa. Pathol Res Pract. 1988;184:1-5. https://doi.org/10.1016/S0344-0338(88)80183-3.
82. Chai G, Webb A, Li C, Antaki D, Lee S, Breuss MW, et al. Mutations in Spliceosomal Genes PPIL1 and PRP17 Cause Neurodegenerative Pontocerebellar Hypoplasia with Microcephaly. Neuron. 2021;109:241-56 e9. https://doi.org/10.1016/j.neuron.2020.10.035.
83. Griffin C and Saint-Jeannet JP. Spliceosomopathies: Diseases and mechanisms. Dev Dyn. 2020;249:1038-46. https://doi.org/10.1002/dvdy.214.
84. Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351:602-11. https://doi.org/10.1016/j.bbrc.2006.10.093.
85. Trabzuni D, Wray S, Vandrovcova J, Ramasamy A, Walker R, Smith C, et al. MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies. Hum Mol Genet. 2012;21:4094-103. https://doi.org/10.1093/hmg/dds238.
86. Rockenstein EM, McConlogue L, Tan H, Power M, Masliah E, and Mucke L. Levels and alternative splicing of amyloid beta protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease. J Biol Chem. 1995;270:28257-67. https://doi.org/10.1074/jbc.270.47.28257.
87. Buee L, Bussiere T, Buee-Scherrer V, Delacourte A, and Hof PR. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev. 2000;33:95-130. https://doi.org/10.1016/s0165-0173(00)00019-9.
88. Bai B, Hales CM, Chen PC, Gozal Y, Dammer EB, Fritz JJ, et al. U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer's disease. Proc Natl Acad Sci U S A. 2013;110:16562-7. https://doi.org/10.1073/pnas.1310249110.
89. Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S, et al. The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses. Curr Protoc Bioinformatics. 2016;54:1 30 1-1 3. https://doi.org/10.1002/cpbi.5.
90. Lam M, Hill WD, Trampush JW, Yu J, Knowles E, Davies G, et al. Pleiotropic Meta-Analysis of Cognition, Education, and Schizophrenia Differentiates Roles of Early Neurodevelopmental and Adult Synaptic Pathways. Am J Hum Genet. 2019;105:334-50. https://doi.org/10.1016/j.ajhg.2019.06.012.
91. Merkin J, Russell C, Chen P, and Burge CB. Evolutionary dynamics of gene and isoform regulation in Mammalian tissues. Science. 2012;338:1593-9. https://doi.org/10.1126/science.1228186.
92. Consortium GT. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science. 2020;369:1318-30. https://doi.org/10.1126/science.aaz1776.